Phibro Animal Health (PAHC) ROE: History & Chart

Phibro Animal Health Corporation(PAHC)

Drug Manufacturers - Specialty & Generic · Teaneck, NJ

$36.81-0.38 (-1.02%)

Delayed quote: Oct 6, 2026, 1:20 PM EDT

About Phibro Animal Health Corporation

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.

Teaneck, NJ

2,605 employees

www.pahc.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Daniel Bendheim

View full financials

PAHC Return on Equity (ROE) Metrics

RETURN ON EQUITY (ROE)

25.87%

RETURN ON EQUITY (ROE) AVG TTM

23.71%

RETURN ON EQUITY (ROE) AVG 3Y

13.50%

RETURN ON EQUITY (ROE) AVG 5Y

15.42%

RETURN ON EQUITY (ROE) AVG 10Y

22.38%

RETURN ON EQUITY (ROE) AVG 15Y

N/A

RETURN ON EQUITY (ROE) AVG 20Y

N/A

CURRENT VS TTM AVG

+9.11%

CURRENT VS 3Y AVG

+91.65%

CURRENT VS 5Y AVG

+67.75%

CURRENT VS 10Y AVG

+15.58%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-41.15%

median of 708 covered companies

CURRENT VS SECTOR MEDIAN

+162.87%

vs the sector median at left

NAME	MARKET CAP	RETURN ON EQUITY (ROE)	TTM	3Y	5Y
Phibro Animal Health Corporation (PAHC)	$1.49B	25.87%	23.71%	13.50%	15.42%
Eton Pharmaceuticals, Inc. (ETON)vs ›	$1.49B	27.24%	-16.62%	-27.07%	-49.65%
Rapport Therapeutics, Inc. Common Stock (RAPP)vs ›	$1.46B	-32.43%	-24.32%	8.11%	8.11%
GH Research PLC (GHRS)vs ›	$1.46B	-17.32%	-19.51%	-16.07%	-12.58%
uniQure N.V. (QURE)vs ›	$1.52B	-77.83%	1723.94%	818.18%	546.13%
Nutex Health, Inc. (NUTX)vs ›	$1.53B	45.63%	28.57%	-115.12%	-36.89%
Healthcare Services Group, Inc. (HCSG)vs ›	$1.45B	23.70%	9.74%	8.98%	11.20%
Stoke Therapeutics, Inc. (STOK)vs ›	$1.53B	-60.17%	-20.40%	-40.27%	-36.46%
Certara, Inc. (CERT)vs ›	$1.44B	-7.08%	-0.64%	-1.30%	-2.08%
Syndax Pharmaceuticals, Inc. (SNDX)vs ›	$1.54B	-1462.12%	-276.13%	-155.50%	-107.48%

NAME

MARKET CAP

RETURN ON EQUITY (ROE)

TTM

Phibro Animal Health Corporation (PAHC)

$1.49B

25.87%

23.71%

13.50%

15.42%

Eton Pharmaceuticals, Inc. (ETON)vs ›

$1.49B

27.24%

-16.62%

-27.07%

-49.65%

Rapport Therapeutics, Inc. Common Stock (RAPP)vs ›

$1.46B

-32.43%

-24.32%

8.11%

GH Research PLC (GHRS)vs ›

$1.46B

-17.32%

-19.51%

-16.07%

-12.58%

uniQure N.V. (QURE)vs ›

$1.52B

-77.83%

1723.94%

818.18%

546.13%

Nutex Health, Inc. (NUTX)vs ›

$1.53B

45.63%

28.57%

-115.12%

-36.89%

Healthcare Services Group, Inc. (HCSG)vs ›

$1.45B

23.70%

9.74%

8.98%

11.20%

Stoke Therapeutics, Inc. (STOK)vs ›

$1.53B

-60.17%

-20.40%

-40.27%

-36.46%

Certara, Inc. (CERT)vs ›

$1.44B

-7.08%

-0.64%

-1.30%

-2.08%

Syndax Pharmaceuticals, Inc. (SNDX)vs ›

$1.54B

-1462.12%

-276.13%

-155.50%

-107.48%

Return on Equity (ROE) FAQ

What is the return on equity (ROE) for Phibro Animal Health Corporation (PAHC)?

The return on equity (ROE) for PAHC stock is 25.87%.

Is Phibro Animal Health Corporation's return on equity (ROE) high or low?

The return on equity (ROE) of 25.87% is 68% above its 5-year average of 15.42%, near the high end of its 5-year range (0.94%–27.71%).

What is the TTM average return on equity (ROE) for Phibro Animal Health Corporation (PAHC)?

The TTM average return on equity (ROE) for PAHC stock is 23.71%.

What is the 3Y average return on equity (ROE) for Phibro Animal Health Corporation (PAHC)?

The 3Y average return on equity (ROE) for PAHC stock is 13.50%.

What is the 5Y average return on equity (ROE) for Phibro Animal Health Corporation (PAHC)?

The 5Y average return on equity (ROE) for PAHC stock is 15.42%.

What is the 10Y average return on equity (ROE) for Phibro Animal Health Corporation (PAHC)?

The 10Y average return on equity (ROE) for PAHC stock is 22.38%.

DATE	RETURN ON EQUITY (ROE)
2026-06-30	25.87%
2026-03-31	26.32%
2025-12-31	27.71%
2025-09-30	21.76%
2025-06-30	16.89%
2025-03-31	11.95%
2024-12-31	7.83%
2024-09-30	6.73%
2024-06-30	0.94%
2024-03-31	4.87%
2023-12-31	5.46%
2023-09-30	7.59%
2023-06-30	11.54%
2023-03-31	10.50%
2022-12-31	13.50%
2022-09-30	17.70%
2022-06-30	18.74%
2022-03-31	22.03%
2021-12-31	22.27%
2021-09-30	20.84%
2021-06-30	22.80%
2021-03-31	19.87%
2020-12-31	20.74%
2020-09-30	22.52%
2020-06-30	17.83%
2020-03-31	18.79%
2019-12-31	17.50%
2019-09-30	19.79%
2019-06-30	25.33%
2019-03-31	31.82%
2018-12-31	35.57%
2018-09-30	33.99%
2018-06-30	35.07%
2018-03-31	31.35%
2017-12-31	36.81%
2017-09-30	40.33%
2017-06-30	42.76%
2017-03-31	46.22%
2016-12-31	52.72%
2016-09-30	74.44%
2016-06-30	91.41%
2016-03-31	93.28%
2015-12-31	137.55%
2015-09-30	259.06%
2015-06-30	203.46%
2015-03-31	163.40%
2014-12-31	94.67%
2014-09-30	53.46%
2014-06-30	-20.36%

DATE

RETURN ON EQUITY (ROE)

2026-06-30

25.87%

2026-03-31

26.32%

2025-12-31

27.71%

2025-09-30

21.76%

2025-06-30

16.89%

2025-03-31

11.95%

2024-12-31

7.83%

2024-09-30

6.73%

2024-06-30

0.94%

2024-03-31

4.87%

2023-12-31

5.46%

2023-09-30

7.59%

2023-06-30

11.54%

2023-03-31

10.50%

2022-12-31

13.50%

2022-09-30

17.70%

2022-06-30

18.74%

2022-03-31

22.03%

2021-12-31

22.27%

2021-09-30

20.84%

2021-06-30

22.80%

2021-03-31

19.87%

2020-12-31

20.74%

2020-09-30

22.52%

2020-06-30

17.83%

2020-03-31

18.79%

2019-12-31

17.50%

2019-09-30

19.79%

2019-06-30

25.33%

2019-03-31

31.82%

2018-12-31

35.57%

2018-09-30

33.99%

2018-06-30

35.07%

2018-03-31

31.35%

2017-12-31

36.81%

2017-09-30

40.33%

2017-06-30

42.76%

2017-03-31

46.22%

2016-12-31

52.72%

2016-09-30

74.44%

2016-06-30

91.41%

2016-03-31

93.28%

2015-12-31

137.55%

2015-09-30

259.06%

2015-06-30

203.46%

2015-03-31

163.40%

2014-12-31

94.67%

2014-09-30

53.46%

2014-06-30

-20.36%

Return on Equity (ROE): 25.87%

PAHC Return on Equity (ROE)

PAHC Average Return on Equity (ROE) Chart

PAHC Current vs Average Return on Equity (ROE) Chart

PAHC Return on Equity (ROE) Metrics

PAHC Competitors' Return on Equity (ROE)

Return Analysis

Return on Equity (ROE) Formula & Definition

Return on Equity (ROE) FAQ

PAHC Return on Equity (ROE) History

Related Metrics